Q1 2020 Holdings
Filed 2020-05-13 | 150 holdings | $214.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $125.0M | 1,109,874 | 58.4% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $31.4M | 1,933,221 | 14.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $20.3M | 240,046 | 9.5% |
| Biogen Inc(BIIB) | COMM | 09062X103 | $16.7M | 52,628 | 7.8% |
| Align Technology Inc(ALGN) | COMM | 016255101 | $8.1M | 46,500 | 3.8% |
| Axsome Therapeutics Inc(AXSM) | COMM | 05464T104 | $4.3M | 73,163 | 2.0% |
| Abbvie Inc(ABBV) | COMM | 00287Y109 | $3.8M | 50,000 | 1.8% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $2.0M | 1,911,573 | 0.9% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $1.6M | 815,690 | 0.8% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $135.8K | 1,885,602 | 0.1% |
| Nextcure, Inc | COMM | 65343E108 | $99.0K | 2,671,856 | 0.0% |
| Natera(NTRA) | COMM | 632307104 | $92.6K | 3,100,560 | 0.0% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $84.2K | 1,417,258 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $57.3K | 2,194,278 | 0.0% |
| Merck & Co Inc(MRK) | COMM | 58933Y105 | $35.7K | 463,795 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $29.3K | 3,083,712 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COMM | 015351109 | $27.6K | 307,300 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $23.7K | 1,961,039 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $22.1K | 233,559 | 0.0% |
| Amarin | ADR | 023111206 | $20.8K | 5,208,305 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMM | 92532F100 | $20.4K | 85,664 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $14.8K | 165,160 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $14.3K | 922,700 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $14.0K | 2,400,000 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $13.2K | 2,266,666 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $13.0K | 292,217 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $11.4K | 4,749,623 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COMM | 803607100 | $9.9K | 101,603 | 0.0% |
| Kala Pharmaceuticals Inc | COMM | 483119103 | $9.8K | 1,114,520 | 0.0% |
| MyoKardia Inc | COMM | 62857M105 | $8.2K | 175,118 | 0.0% |
| Gilead Sciences IncCall | COMM | 375558903 | $7.5K | 100,000 | 0.0% |
| Kala Pharmaceuticals IncPut | COMM | 483119953 | $6.5K | 737,300 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $6.4K | 1,526,178 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $6.0K | 1,630,221 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COMM | 604749101 | $5.9K | 418,589 | 0.0% |
| Heron Therapeutics Inc(HRTX) | COMM | 427746102 | $5.7K | 481,608 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COMM | 74587V107 | $5.4K | 638,026 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COMM | 03152W109 | $4.9K | 525,530 | 0.0% |
| Iterum Therapeutics | COMM | G6333L101 | $4.7K | 1,726,514 | 0.0% |
| Iovance Biotherapeutics IncCall | COMM | 462260900 | $4.5K | 150,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COMM | 09627Y109 | $3.7K | 63,100 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COMM | 13089P101 | $3.6K | 819,002 | 0.0% |
| Homology Medicines Inc | COMM | 438083107 | $3.6K | 230,663 | 0.0% |
| Applied Genetic Technologies Corp(2GT) | COMM | 03820J100 | $3.5K | 1,062,615 | 0.0% |
| Akero Therapeutics IncPut | COMM | 00973Y958 | $3.2K | 150,000 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COMM | 00973Y108 | $3.1K | 148,415 | 0.0% |
| Entasis Therapeutics Holdings Inc. | COMM | 293614103 | $3.1K | 1,180,178 | 0.0% |
| Otonomy Inc | COMM | 68906L105 | $3.0K | 1,515,629 | 0.0% |
| Alnylam Pharmaceuticals IncCall | COMM | 02043Q907 | $2.9K | 27,100 | 0.0% |
| TG Therapeutics Inc(TGTX) | COMM | 88322Q108 | $2.7K | 275,305 | 0.0% |